Abstract
A number of factors have been proposed to account for the lack of response to medical therapy in patients with gastroesophageal reflux; however, no controlled studies are available in the literature. The goal of this study was to determine possible causes of medical refractoriness in patients with gastroesophageal reflux. Gastric acid output and esophageal acid exposure were measured in patients who continue to have reflux symptoms despite aggressive antisecretory therapy. In addition, an upper endoscopy was also performed in each patient. Patients with a drug-controlled acid output < 1 mEq/hr and a supine total esophageal pH < 4 for less than 1.7% of the time measured were considered responsive to therapy; on the other hand, those with a drug-controlled gastric acid output > 1 mEq/hr and a supine esophageal pH < 4 for more than 1.7% of the time measured were considered resistant to therapy. Twenty -four patients met the inclusion criteria (13 male and 11 female; mean age, 52). Drug-controlled gastric acid output was more than 1 mEq/hr in 25% of patients and less than 1 mEq/hr in the remainder. Of those patients with a gastric acid output of less than 1 mEq/hr (18 patients), 8(44%) had a supine esophageal pH < 4 for more than 1.7% of the time, suggesting that factors other than gastroesophageal reflux likely contributed to their reflux-like symptoms. Acid suppression appears adequate in the majority of patients with gastroesophageal reflux refractory to medical therapy. The exact cause of persistent reflux-like symptoms in patients who fail medical treatment is uncertain but may be related to non-acid-related factors such as esophageal hypersensitivity to physiologic reflux, increased intake of air resulting in aerophagia, or other factors such as bile reflux.
Similar content being viewed by others
References
An evidence based appraisal of reflux disease management the Geneva Workshop Report. Gut 44(2):S1–S16, 1999
Leite LP, Johnston BT, Just RJ, Castell DO: Persistent acid secretion during ompeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91:1527–1531, 1996
Collen MJ, Lewis JH, Benjamin SB: Gastric acid hypersecretion in refractory gastroesophageal disease. Gastroenterology 98:654–661, 1990
Pandolfino JE: Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98:740–749, 2003
Knuff TE, Benjamin SB, Worsham F, et al.: Histologic evaluation of chronic gastroesophageal reflux. An evaluation of biopsy methods and diagnostic criteria. Dig Dis Sci 29:194–201, 1984
Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA: Functional esophageal disorders. Gut 45 (Suppl II):II31–II36, 1999
Cannon RO, Benjamin SB: Chest pain as a consequence of abnormal visceral nociception. Dig Dis Sci 38(2):193–196, 1993
Attwood SEA, Ball CS, Barlow AP, et al.: Role of intragastric and intraesophageal alkalinization in the genesis of complications in Barrett's columnar lined lower esophagus. Gut 34:11–15, 1993
Champion G, Richter JE, Vaezi MF, et al.: Duodenogastroesophageal refux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 107:747–754, 1994
Drossman DA: Importance of the psyche in heartburn and dyspepsia. Aliment Pharmacol Ther 11 (Suppl 2):57–67, 1997
Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS: Low dose trazodone for symptomatic patients with esophageal contraction abnormalities: double blind placebo controlled trial. Gastroenterology 92:1027–1036, 1986
Foud YM, Katz PO, Castell DO: Patients with refractory nocturnal gastroesophageal reflux have more prevalent esophageal motility abnormalities. Am J Gastroenterol 93:1615, 1998
Kauer WKH, Peters JH, DeMeester TR, et al.: Mixed reflux of gastric and duodenal juice is more harmful to the esophagus than gastric juice alone. Ann Surg 222:525–533, 1995
Vela M, Camacho-Lobato L, Hatlebakk J, et al.: Effect of omeprazole on ratio of acid to nonacid gastroesophageal reflux: Studies using simultaneous intraesophageal impedance and pH measurement. Gastroenterology 116:G0910, 1999
Kamolz T: Comorbidity of aerophagia in GERD patients:outcome of laparoscopic antireflux surgery. Scand J Gastroenterol 37(2):138–143, 2002
Hirschowitz BI: A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149–1158, 1991
Sagar M, Seensalu R, Tybring G, et al.: CYP2C19 genotype and pheotype determined with omeprazole in patients with acid-related disorders with and without Helicobacter pylori infection. Scand J Gastroenterol 33:1034–1038, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahlawat, S.K., Mohi-Ud-Din, R., Williams, D.C. et al. A Prospective Study of Gastric Acid Analysis and Esophageal Acid Exposure in Patients with Gastroesophageal Reflux Refractory to Medical Therapy. Dig Dis Sci 50, 2019–2024 (2005). https://doi.org/10.1007/s10620-005-3001-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-3001-2